Intratumoral heterogeneity drives cancer recurrence and metastasis, yet single-cell drug response prediction faces severe “cross-domain” challenges, such as applying in vitro models to in vivo tissues or inferring metastatic resistance from primary tumors. These scenarios trigger distribution shifts arising from heterogeneous sequencing platforms, distinct tissue microenvironments, and metastatic evolution—problems rarely addressed by existing methods. We introduce CSGDA, a cell state-guided graph domain adaptation framework designed to predict drug responses across these biological heterogeneities. CSGDA incorporates biological priors to map gene expression into functional cell states, guiding a structure learning module to construct robust cell topology. To conquer distribution shifts, the model employs graph domain adaptation combined with a novel overlap penalty mechanism. Extensive benchmarks on five scRNA-seq datasets demonstrate that CSGDA outperforms state-of-the-art methods, achieving an average gain of ∼6% in ACC and AUPR. Beyond prediction accuracy, we employed integrated gradients to effectively pinpoint key genes involved in drug resistance within a challenging cross-metastasis cisplatin dataset. These findings underscore CSGDA’s superior performance in single-cell drug response prediction and its potential in resolving single-cell heterogeneity, paving the way for precision medicine.
Fen Yan, Xi-Yue Cao, Feiqiao Mao et al.· bioRxiv· 0 citations
Vision–language pretrained models, particularly CLIP, have demonstrated remarkable zero-shot transfer capabilities across various image-level tasks, catalyzing the advancement of open-vocabulary semantic segmentation (OVSS) in remote sensing (RS). However, the direct deployment of CLIP to the RS domain is inherently constrained by the profound domain shift between terrestrial and overhead perspectives, as well as the intricate geometric heterogeneities regarding scale and orientation. To circumvent these limitations, we propose CDSeg, a robust framework tailored for RSOVSS. Central to this architecture is the dual-domain feature compensation module (DDFCM), which integrates DINOv3 weights, pretrained on large-scale RS benchmarks, to augment CLIP with domain-specific semantic priors, effectively bridging the natural-to-satellite knowledge gap. Furthermore, we introduce a MambaVision-driven cross-feature fine-grained interaction module (CFFIM) to facilitate a unified refinement of spatial and category attributes, leveraging long-range dependency modeling to enhance the model’s discriminative power in unseen environments. To robustly manage the complexities of diverse orientations and scales, CDSeg incorporates a direction-aware rotation strategy and a wavelet-cross-attention-enhanced module (WCAEM) for high-fidelity multiscale feature decoding. Empirical evaluations on four public benchmarks demonstrate that CDSeg achieves state-of-the-art (SOTA) performance, while extensive ablation studies substantiate the synergistic contribution and indispensability of each component.
Jiayuan Li, Zhen Wang, Xiao Sun et al.· IEEE Transactions on Geoscie...· 0 citations
Cross-patient cell-type annotation in single-cell RNA sequencing (scRNA-seq) remains challenging due to pronounced interpatient heterogeneity and distribution shifts across patient-specific cellular contexts. Conventional annotation approaches often rely on proximity-driven graph construction or expression similarity, which may introduce spurious cell-cell connections and lead to unstable knowledge transfer across patients. To address this limitation, we propose PathoGraph, a functionally guided graph learning framework for robust cross-patient cell-type annotation. The proposed method integrates KEGG-7-based biosemantic graph structure learning with cross-patient representation adaptation. Specifically, pathway-derived functional semantic profiles are incorporated to refine patient-specific cell graphs, encouraging biologically coherent neighborhoods and suppressing noise introduced by purely expression-based similarity. Based on the refined graphs, a cross-patient representation adaptation mechanism further aligns embeddings between labeled reference patients and unlabeled query patients to facilitate reliable annotation transfer. Experiments on three cross-patient scRNA-seq data sets, including leukemia, breast invasive carcinoma, and colorectal cancer data sets, demonstrate that PathoGraph achieves stable annotation performance across 32 directed reference-to-query transfer tasks. Across all tasks, PathoGraph obtained an average ACC of 84.28% and an F1-score of 84.08%, showing competitive and stable performance compared with representative marker-based, correlation-based, and model-based annotation methods. Ablation studies further show that removing the biosemantic graph learning module reduces the average accuracy to 83.48%, highlighting the importance of functional-guided graph refinement. In addition, post hoc functional relevance analyses in immune-cell and cancer-associated contexts suggest that the learned cell-cell graphs capture biologically relevant neighborhood structures beyond expression-driven proximity. The source code and processed data are publicly available at: https://github.com/LiYuechao1998/PathoGraph.
Yue C. Li, Mengmeng Wei, Xinfei Wang et al.· Journal of Chemical Informat...· 0 citations